LOGIN 20 September 2021
Pharmaceutical product launches come with a number of challenges when launching a new drug into the market. Streamlining the market access strategy for an asset is greatly improved with strong data and data analytics, powered by AI.
GPI’s pricing and marketing access data analytics platform is designed with powerful near-time pharma data across 95+ countries, standardising disparate data sources, allowing companies to create efficient market access strategies. GPI’s platform is designed to support a successful pricing and market access strategy, throughout the drug lifecycle. The following infographic helps to illustrate how GPI collects, standardises and displays the data, to provide all the information your company needs for a successful market access strategy.
10 STEPS FOR A SUCCESSFUL MARKET ACCESS STRATEGY
GPI pulseTM 2.0, GPI’s value, price and access data analytics platform, combines unrivalled disparate data from over 95 countries to provide the information you need for your market access strategy.
The best market access strategies are created from the best data, and at GPI, data is at the core of our services, which also includes expert consulting capabilities, sophisticated analytics platform and a proprietary methodology. GPI provides the data you need, whilst innovative machine learning leverages and cleanses the data, making it easily digestible for successful market access strategies to be created.
At the ‘Verify’ stage the product goes through Quality, verification and Release which assess how the product will perform in the market. The ‘3-Eye-Checks’ consists of machine algorithms, data analysts and domain experts, ensuring quality and accurate information about the market access strategy, and ultimately better decision making.
The ‘outputs’ stage allows you to see a clear pathway to commercial success. Reports from the data analytics can be generated through intelligent integration, which allows you to see a clear picture. The GPI platform dashboard is flexible, allowing you to connect with your existing systems and provide more intuitive, seamless flow of data.
Finally, GPI’s team of experienced consultants can provide further in-depth market access strategies from early development to post launch. Our pharma industry consultants’ partner with a range of clients, helping to understand the data, and to provide clear, effective market access strategies.